Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr 16:9:114.
doi: 10.3389/fendo.2018.00114. eCollection 2018.

Nontoxic Goiter (NTG) and Radioiodine: What Do Patients Think About It? Quality of Life in Patients with NTG Before and After 131-I Therapy

Sonia Kaniuka-Jakubowska  1 , Anna Lewczuk  1 , Mikołaj Majkowicz  2   3 , Maciej Piskunowicz  4 , Krystyna Mizan-Gross  5 , Adam Zapaśnik  4 , Mariusz Kaszubowski  6 , Piotr Lass  5   7 , Krzysztof Sworczak  1
Affiliations

Nontoxic Goiter (NTG) and Radioiodine: What Do Patients Think About It? Quality of Life in Patients with NTG Before and After 131-I Therapy

Sonia Kaniuka-Jakubowska et al. Front Endocrinol (Lausanne). .

Abstract

Objective: Despite numerous publications regarding nontoxic goiter (NTG) treatment and an increasing interest in patients' quality of life, few studies present the outcome of 131-I treatment from the patients' perspective. Our study's main aim was to verify whether there is any improvement in life quality following 131-I treatment.

Materials and methods: Thirty-five patients with NTG qualified to participate in the study. All patients completed a Thyroid-Related Health-Related Quality of Life (Thy-R-HRQoL) questionnaire created by us and the Medical Outcomes Study 36-item Short Form (SF-36), right before and 1 year after 131-I.

Results: We observed an improvement in six out of eight SF-36 and three out of seven Thy-R-HRQoL domains. In comparison with the control group, we observed worse results in two out of eight, prior to treatment, and one out of eight SF-36 afterward, as well as in all Thy-R-HRQoL domains. We did not find any correlation between improvement of Thy-R-HRQoL and SF-36 and goiter size reduction, except for Bodily Pain. There was also no correlation between improvement of SF-36 and Thy-R-HRQoL domains, and goiter size before treatment. The older the patient, the less noticeable improvement was observed in Physical and Social Functioning, and Vitality in SF-36, but age had no influence on the assessment by Thy-R-HRQoL.

Conclusion: Radioiodine treatment improves life quality in patients with NTG. Use of the Health-Related Quality of Life questionnaire should be taken into consideration when evaluating life quality of patients with NTG. Relentless pursuit of maximal goiter size reduction in 131-I treatment is worth consideration. In our study, life quality improvement did not depend directly on the goiter size reduction. Life quality improvement after 131-I might not depend on initial goiter size, and for certain domains of SF-36 might be less clearly expressed in older patients.

Keywords: 36-item Short Form; life quality; nontoxic goiter; quality of life; radioiodine.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Hegedüs L, Bonnema SJ, Bennedbaek FN. Management of simple nodular goiter: current status and future perspectives. Endocr Rev (2003) 24(1):102–32.10.1210/er.2002-0016 - DOI - PubMed
    1. Kaniuka S, Lass P, Sworczak K. Radioiodine – an attractive alternative to surgery in large non-toxic multinodular goitres. Nucl Med Rev Cent East Eur (2009) 12(1):23–9. - PubMed
    1. Kaniuka-Jakubowska S, Lewczuk A, Mizan-Gross K, Piskunowicz M, Zapaśnik A, Lass P, et al. Large multinodular goiter-outpatient radioiodine treatment. Endokrynol Pol (2015) 66(4):301–7.10.5603/EP.2015.0038 - DOI - PubMed
    1. Fast S, Nielsen VE, Grupe P, Boel-Jørgensen H, Bastholt L, Andersen PB, et al. Prestimulation with recombinant human thyrotropin (rhTSH) improves the long-term outcome of radioiodine therapy for multinodular nontoxic goiter. J Clin Endocrinol Metab (2012) 97(8):2653–60.10.1210/jc.2011-3335 - DOI - PubMed
    1. Kaniuka-Jakubowska S, Piskunowicz M, Zapaśnik A, Lewczuk A, Kaniuka A, Mizan-Gross K, et al. US not bright but right method of thyroid volume estimation even in large and substernal extended goitres. Comparison of US and three methods of CT thyroid evaluation – prospective study. Clin Endocrinol (Oxf) (2015) 83(3):412–9.10.1111/cen.12629 - DOI - PubMed

LinkOut - more resources